Abstract: A liquid crystal display device includes: a pair of substrates; a liquid crystal layer between the pair of substrates; and an alignment film between at least one of the pair of substrates and the liquid crystal layer, wherein the alignment film includes a first and second component, wherein the first component is a polymer in which at least two types of liquid crystal orientation side chains are bonded to a polysiloxane main chain, wherein the second component is made of at least one of a polyamic acid and a polyimide, wherein the at least two types of liquid crystal orientation side chains include a first side chain having on an end thereof a fluorine atom, and a second side chain that does not have on an end thereof a fluorine atom, wherein a proportion of the first component to a total amount of the second component is 2 mass % or greater, and wherein, in the liquid crystal display device, liquid crystal is sealed between the pair of substrates by a One Drop Fill scheme.

Abstract: The present invention relates to bicyclic himbacine derivatives of the formula or a pharmaceutically acceptable salt thereof wherein: R1 is —[C(Ra)(Rb)]x—[C(Rb)(Rb)]y—C(O)NH2, or —N(H)—[(CH2)]z—C(O)—NH2, W is and the remaining variables are described herein. The compounds of the invention are effective inhibitors of the PAR-1 receptor. The inventive compounds may be used for the treatment or prophylaxis of disease states such as ASC, secondary prevention of myocardial infarction or stroke, or PAD.

Abstract: The present invention is directed to thiazole compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the thiazole compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to pharmaceutical compositions comprising these compounds. The present invention is also directed to uses of these pharmaceutical compositions in the prevention or treatment of such diseases in which orexin receptors are involved.

Abstract: Included are: refresh a rate changing section (15) for changing a refresh rate of a display panel (2) by configuring settings for scan periods during each of which a plurality of gate signal lines (G) of the display panel (2) are sequentially scanned and for pause periods during each of which sequential scanning of the plurality of gate signal lines (G) is suspended; and a drive amount control section (20) for controlling, in accordance with a ratio of the scan periods to the pause periods, drive time during which each of the gate signal lines is driven in each of the scan periods.

Abstract: This semiconductor device (100A) includes: a substrate (2); a gate electrode (3) formed on the substrate (2); a gate insulating layer (4) formed over the gate electrode (3); an oxide semiconductor layer (5) formed on the gate insulating layer (4); source and drain electrodes (6s, 6d) electrically connected to the oxide semiconductor layer (5); a first transparent electrode (7) electrically connected to the drain electrode (6d); an interlayer insulating layer (8a) including portions formed on the source and drain electrodes (6s, 6d); and a second transparent electrode (9) formed on the interlayer insulating layer (8a). At least a portion of the second transparent electrode (9) overlaps with the first transparent electrode (7) with the interlayer insulating layer (8a) interposed between them. And the oxide semiconductor layer (5) and the first transparent electrode (7) are formed out of a same oxide film.

Abstract: An active matrix substrate (1) includes a source electrode (32), a drain electrode (33), and a semiconductor layer (31) of oxide semiconductor. A gate insulating layer (42) of silicon oxide is formed on the gate electrode (12a); a source electrode (32), a drain electrode (33), and a semiconductor layer (31) are formed on the gate insulating layer (42); a first protection layer (44) of silicon nitride is formed on the gate insulating layer (42) without covering the semiconductor layer (31); and a second protection layer (46) of silicon oxide is formed on the semiconductor layer (31). The first protection layer (44) covers the signal line (14) and the source connection line (36).

Abstract: A coding device and a decoding device are configured to include an estimated prediction mode deciding section (122a) including: a reference block selecting section (1223a) for selecting a reference block for use in estimating an intra-prediction mode for a subject block; an estimating number deciding section (1222a) for deciding an estimating number of estimated values to be estimated for the intra-prediction mode; and an estimated prediction mode deriving section (1221a) for estimating, based on a reference block, the estimating number of estimated values of the prediction mode.

Abstract: According to the present invention, a liquid crystal display device driven by a transverse electric field system, which can prevent the occurrence of color unevenness in display, is provided. Namely, the liquid crystal display device of the present invention includes: a first substrate, a second substrate, and a liquid crystal layer interposed between the first substrate and the second substrate. The first substrate includes a first shield electrode with translucency, a supporting substrate, a light shielding layer, and a colored layer. The second substrate includes a common electrode and a pixel electrode, and assuming that the liquid crystal layer is the center of the liquid crystal display device, the first shield electrode is provided outwardly from the supporting substrate when seen from the center. The liquid crystal display device further comprises a first controlling circuit configured to apply a positive electric potential to the first shield electrode.

Abstract: The present invention relates to methods of inducing an immune response to Staphylococcus comprising administering a composition comprising an SA2493-related polypeptide from Staphylococcus aureus as well as derivatives or fragments thereof. The present invention also encompasses methods of treating and/or reducing the likelihood of a Staphylococcus infection by administering a composition comprising an SA2493-related polypeptide or an antibody that specifically binds to an SA2493 polypeptide, derivative or fragments thereof. Compositions administered in the methods of the invention can include one or more additional antigens including, but not limited to, IsdB. Compositions used to practice the methods of the invention are also encompassed.

Abstract: Low frequency drive is performed that provides, after a charging period for refreshing a screen, a pause period for pausing the refresh. The length of the charging period is, for example, one frame and the length of the pause period is, for example, 59 frames. When new image data IMD is transmitted from a host to an LCD driver IC during the pause period, an interrupt process where the pause period is allowed to transition to the charging period is performed immediately thereafter. By performing the interrupt process, without waiting for the pause period with the predetermined length to end, the next charging period where refresh based on the new image data IMD is to be performed starts.

Abstract: A light source system comprising a projection lens, which is capable of producing a far-field image of a light source. The light source comprises a photoluminescent material that when illuminated by light from laser emitters of a first waveband emits light of a second or more wavebands of longer wavelength. The resulting light emission produces a color perceived as white. The light source is illuminated by a plurality of laser emitters arranged to illuminate the light source in an array-like manner from the front side. Control of the output of one or more of the laser emitters results in a variation of the spatial emission distribution from the light source and hence a variation of the far-field beam spot distribution via non-mechanical means. An optical system is arranged to image light emitted from the photoluminescent material into the far-field, which optical system comprises a converging lens.

Abstract: A TFT 1 is formed on a glass substrate 11, and a flattening resin film 17 covering the TFT 1 is formed. Furthermore, a moisture-proof protective film 18 covering the entire surface of the flattening resin film 17 is formed. For the protective film 18, a SiO2 film, a SiN film, a SiON film, or a stacked film thereof is used. The edge surfaces of the flattening resin film 17 are disposed on the inner side of or under a seal 4, and are formed in a tapered shape. By this, the entry of moisture into the flattening resin film 17 is prevented, preventing display degradation. This effect becomes noticeable in a display device including an oxide semiconductor TFT.

Abstract: A display device which makes the frame hardly visible to the viewer is provided. This display device includes: a display panel (10) having a display area (RA) and a frame area (RF) provided outside of the display area; and a light-transmitting cover (20) which is arranged closer to a viewer than the display panel is and which includes lens portions (22) that are arranged at positions corresponding to the boundary between the display area and frame area of the display panel. The display panel (10) has a planar shape which includes four sides (10a) that define upper, lower, right and left sides, respectively, and four corner portions (10b), each connecting two associated adjacent ones of the four sides together. The display panel further has a chamfered portion (10c) with a curved or straight edge which is arranged in at least one of the four corner portions inside of the intersection between extended lines of the two adjacent sides.

Abstract: A nanoparticle phosphor includes a nanoparticle composed of a compound semiconductor containing a first metal atom, and an inorganic substance layer provided on at least a part of the surface of the nanoparticle and containing the first metal atom and one or more kinds of hetero atoms. In the inorganic substance layer, the first metal atom is bound to the hetero atom.

Abstract: Thiazolidinone compounds, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis.

Abstract: The invention provides certain substituted pyridines of the Formula (I) or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, Rcy, Cy, and t are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated by Spleen Tyrosine Kinase (Syk) kinase.

Abstract: A method is provided for an electronics device user interface (UI) to create a rules-validated service request. Initially, a UI device presents a plurality of selections, and accepts a selection command from a user. A UI application sends the selection command to a rules engine. The rules engine compares the selection command to a rules collection cross-referencing selection commands to allowable selection commands, wherein a rule is defined as a relationship between service parameters. In response to the rules engine validating the selection commands, the UI application sends a service request including the selection commands to a service device, and the service device performs a service defined in the service request. In response to the rules engine invalidating the selection command, the UI device may present an explanation of a rule violation associated with the invalid selection command. An associated system is also provided.

Abstract: The invention is directed to novel bis-quarternary cinchona alkaloid salts and the use of bis-quarternary cinchona alkaloid salts in asymmetric phase transfer catalysis. The present invention is directed to novel bis-quarternary cinchona alkaloid salts and the use of bis-quarternary cinchona alkaloid salts in asymmetric phase transfer catalysis. On certain substrates and under specific reaction conditions, the inventors have discovered that the use of bis-quarternary cinchona alkaloid salts in asymmetric phase transfer catalysis surprisingly provides for a more active and efficient process as compared to mono-quarternary catalysts.

Abstract: A toner storage device includes a toner storage case that stores toner, and a stirring paddle rotatably supported in the toner storage case and includes at least one stirring blade that stirs the toner stored in the toner storage case, and a rotating shaft that rotates the at least one stirring blade, wherein the toner storage case includes a first supporting portion that rotatably supports an end of the rotating shaft of the stirring paddle, a second supporting portion that rotatably supports an other end of the rotating shaft, and a tapered portion that is tapered toward the first supporting portion.

Abstract: To provide a display device capable of offering improved radiation performance of radiating heat generated from a driver IC arranged to drive a display panel. The display device (1) includes a display panel (10) arranged to display an image, a driver IC (17) electrically connected to the display panel via a connecting member (18) and arranged to drive the display panel, and a housing member that defines a case of the display device, wherein the housing member includes a first housing member (11) made from metal and attached to the display panel from a front side of the panel, and a second housing member (22) made from metal and attached to the display panel from a back side of the panel, and wherein the driver IC is held sandwiched between the first housing member and the second housing member.